A review on recent advancements in ophthalmology devices: Currently in market and under clinical trials

Rajini Nagaraj, Divya Rani Bijukumar, Benjamin Mathew, Evan Alexander Scott, Mathew T. Mathew*

*Corresponding author for this work

Research output: Contribution to journalReview article

1 Scopus citations


The complex anatomical features of the eye and the presence of different ocular barriers has led to complications in the development of an effective treatment strategy for posterior segment diseases like diabetic retinopathy, age-related macular degeneration, retinal pigmentosa, etc., thus demanding the need for novel and innovative approaches. There are various treatment options available in the market which includes the new implants and drug delivery systems apart from the therapeutic agents which are benefiting the patients with modern improvements, enhanced formulations, targeted and long-term delivery. But they all still have numerous drawbacks which need to be addressed. This review article discusses and highlights the recent developments made in the ophthalmology which are in the market currently and under clinical trial. This review also suggests a possible alternative system that can be an effective and practical option for the treatment of posterior segment ophthalmic diseases.

Original languageEnglish (US)
Pages (from-to)334-345
Number of pages12
JournalJournal of Drug Delivery Science and Technology
StatePublished - Aug 1 2019



  • Electronic retinal implants
  • Nanoparticle drug delivery systems
  • Ocular diseases
  • Ocular drug delivery
  • Ophthalmic devices
  • Ophthalmic implants

ASJC Scopus subject areas

  • Pharmaceutical Science

Cite this